Acute procedural safety of the latest radiofrequency ablation catheters in atrial fibrillation ablation: Data from a large prospective ablation registry
Hirofumi Arai,Shinsuke Miyazaki,Junichi Nitta,Yukihiro Inamura,Yasuhiro Shirai,Yasuaki Tanaka,Yasutoshi Nagata,Yukio Sekiguchi,Osamu Inaba,Yuichiro Sagawa,Akira Mizukami,Koji Azegami,Shinsuke Iwai,Hitoshi Hachiya,Yuichi Ono,Takeshi Sasaki,Atsushi Takahashi,Yasuteru Yamauchi,Hiroyuki Okada,Atsushi Suzuki,Makoto Suzuki,Keita Handa,Kenzo Hirao,Takuro Nishimura,Susumu Tao,Masateru Takigawa,Tetsuo Sasano
DOI: https://doi.org/10.1111/jce.16408
IF: 2.7
2024-08-28
Journal of Cardiovascular Electrophysiology
Abstract:Background Safety data of the latest radiofrequency (RF) technologies during atrial fibrillation (AF) ablation in real‐world clinical practice are limited. Objectives We sought to evaluate the acute procedural safety of the four latest ablation catheters commonly used for AF ablation. Methods A total of 3957 AF ablation procedures performed between January 2022 and December 2023 at 20 centers with either the THERMOCOOL SMARTTOUCH SF (STSF), TactiCath (TC), QDOT Micro (QDM), or TactiFlex (TF) were retrospectively analyzed. Results In total, QDM, STSF, TF, and TC were used in 343 (8.7%), 1793 (45.3%), 1121 (28.4%), and 700(17.7%) procedures. Among 2406 index procedures, electrical pulmonary vein isolations were successfully achieved in 99.5%. Despite similar total procedure times in the four groups, the total fluoroscopic time was significantly shorter for QDM/STSF with CARTO than TF/TC with EnSite (18.7 ± 14 vs. 27.6 ± 20.6 min, p
cardiac & cardiovascular systems